These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 20817595)

  • 21. Restless legs syndrome prevalence and impact: REST general population study.
    Allen RP; Walters AS; Montplaisir J; Hening W; Myers A; Bell TJ; Ferini-Strambi L
    Arch Intern Med; 2005 Jun; 165(11):1286-92. PubMed ID: 15956009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and clinical correlates of restless legs syndrome in an elderly French population: the synapse study.
    Celle S; Roche F; Kerleroux J; Thomas-Anterion C; Laurent B; Rouch I; Pichot V; Barthélémy JC; Sforza E
    J Gerontol A Biol Sci Med Sci; 2010 Feb; 65(2):167-73. PubMed ID: 19914971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study.
    Winkelman JW; Shahar E; Sharief I; Gottlieb DJ
    Neurology; 2008 Jan; 70(1):35-42. PubMed ID: 18166705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comorbidity in restless legs syndrome among a sample of Swedish adults.
    Ulfberg J; Bjorvatn B; Leissner L; Gyring J; Karlsborg M; Regeur L; Skeidsvoll H; Polo O; Partinen M;
    Sleep Med; 2007 Nov; 8(7-8):768-72. PubMed ID: 17825613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restless legs syndrome--relevant aspects for internal medicine specialists.
    Sitaru C; Cristea V; Florea SM
    Rom J Intern Med; 1999; 37(3):275-86. PubMed ID: 15532306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restless legs syndrome.
    Bayard M; Avonda T; Wadzinski J
    Am Fam Physician; 2008 Jul; 78(2):235-40. PubMed ID: 18697508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antidepressant medication use and restless legs syndrome in patients presenting with insomnia.
    Brown LK; Dedrick DL; Doggett JW; Guido PS
    Sleep Med; 2005 Sep; 6(5):443-50. PubMed ID: 16084763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopa responsive insomnia: a forme fruste or precursor of restless legs syndrome?
    Prakash S
    J Neurol Sci; 2012 May; 316(1-2):170-2. PubMed ID: 22349357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Restless legs syndrome and depression].
    Rasmussen J; Videbech P
    Ugeskr Laeger; 2011 Aug; 173(35):2113-7. PubMed ID: 21884661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort.
    Winkelman JW; Finn L; Young T
    Sleep Med; 2006 Oct; 7(7):545-52. PubMed ID: 16740407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excessive Daytime sleepiness in idiopathic restless legs syndrome: characteristics and evolution under dopaminergic treatment.
    Kallweit U; Siccoli MM; Poryazova R; Werth E; Bassetti CL
    Eur Neurol; 2009; 62(3):176-9. PubMed ID: 19602890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Augmentation and impulsive behaviors in restless legs syndrome: Coexistence or association?
    Heim B; Djamshidian A; Heidbreder A; Stefani A; Zamarian L; Pertl MT; Brandauer E; Delazer M; Seppi K; Poewe W; Högl B
    Neurology; 2016 Jul; 87(1):36-40. PubMed ID: 27261093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical presentation, diagnosis, and quality of life issues in restless legs syndrome.
    Kushida CA
    Am J Med; 2007 Jan; 120(1 Suppl 1):S4-S12. PubMed ID: 17198769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing health-related quality of life in patients with restless legs syndrome.
    Happe S; Reese JP; Stiasny-Kolster K; Peglau I; Mayer G; Klotsche J; Giani G; Geraedts M; Trenkwalder C; Dodel R
    Sleep Med; 2009 Mar; 10(3):295-305. PubMed ID: 18359664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of non-ergot dopamine agonists on health-related quality of life of patients with restless legs syndrome.
    Talati R; Phung OJ; Mather J; Coleman CI
    Ann Pharmacother; 2009 May; 43(5):813-21. PubMed ID: 19401472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health-related quality of life and restless legs syndrome among women in Sweden.
    Wesström J; Nilsson S; Sundström-Poromaa I; Ulfberg J
    Psychiatry Clin Neurosci; 2010 Oct; 64(5):574-9. PubMed ID: 20727108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mood disorders in restless legs syndrome (Willis-Ekbom disease).
    Becker PM; Sharon D
    J Clin Psychiatry; 2014 Jul; 75(7):e679-94. PubMed ID: 25093484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Restless legs syndrome: the most prevalent "unknown" disorder].
    Lindner A; Novák M; Molnár MZ
    Orv Hetil; 2011 Feb; 152(7):259-66. PubMed ID: 21296735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome.
    Saletu M; Anderer P; Saletu-Zyhlarz G; Hauer C; Saletu B
    Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):185-94. PubMed ID: 12242580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes of cortical excitability after dopaminergic treatment in restless legs syndrome.
    Scalise A; Pittaro-Cadore I; Janes F; Marinig R; Gigli GL
    Sleep Med; 2010 Jan; 11(1):75-81. PubMed ID: 19595629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.